ResearcherRoyal College of Surgeons in IrelandActive in the last 2 years

Patrick Glyn Morris

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6055-5273; OpenAlex author ID A5067642403. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

David J. Easty · 1 shared paper, 2026 · strength 0.23
- Paper Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemci… DOI 10.1186/s12885-025-14512-2 ↗
Derek Gerard Power · 1 shared paper, 2026 · strength 0.23
- Paper Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemci… DOI 10.1186/s12885-025-14512-2 ↗
Bryan T. Hennessy · 1 shared paper, 2026 · strength 0.23
- Paper Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemci… DOI 10.1186/s12885-025-14512-2 ↗
Ray McDermott · 1 shared paper, 2026 · strength 0.23
- Paper Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemci… DOI 10.1186/s12885-025-14512-2 ↗
Adrian Gerard Murphy · 1 shared paper, 2026 · strength 0.23
- Paper Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemci… DOI 10.1186/s12885-025-14512-2 ↗
Dearbhaile Catherine Collins · 1 shared paper, 2015 · strength 0.11
- Paper Systemic therapy for advanced pancreatic cancer: individualising cytotoxic therapy. DOI 10.1517/14656566.2015.1024654 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.